Skip to main content
SEOUL PHARMA CO.,LTD logo

SEOUL PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 018680 ISIN · KR7018680009 KO Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2022-02-04 Earnings Release
Country KR South Korea
Listing KO 018680

About SEOUL PHARMA CO.,LTD

http://www.seoulpharmaceuticals.com/

Seoul Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company specializes in innovative drug delivery systems, with a core competency in Orally Disintegrating Film (ODF) technology. Its product portfolio includes a wide range of prescription and over-the-counter medications. Key therapeutic areas cover cardiovascular and respiratory systems, as well as anti-infective agents such as antibacterials, antifungals, and antivirals. The company also produces vitamins and antibiotics, aiming to improve health outcomes through its cutting-edge technological capabilities.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Seoul Pharma) announcing a significant change (over 15%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for preliminary financial results before the final audit is completed. Since it provides key financial highlights and reasons for the variance rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of an Earnings Release (ER) as it serves as the initial announcement of financial performance. FY 2021
2022-02-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Seoul Pharma regarding the setting of a record date and the closure of the shareholder register for the purpose of the 36th Annual General Meeting. It does not contain the full meeting materials or voting results, but rather serves as a formal notice of the administrative procedure for shareholder identification. Given it is a regulatory announcement regarding corporate governance procedures that does not fit into specific categories like AGM-R or DVA, it is classified as a general regulatory filing.
2021-12-15 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Seoul Pharma, covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, business operations, management discussion, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Seoul Pharma, covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial information, business operations, management discussions, and organizational structure. As it is a comprehensive financial report for a period shorter than a full fiscal year (a half-year report) and contains substantive financial data, it is classified as an Interim/Quarterly Report (IR). H1 2021
2021-08-13 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Seoul Pharma, covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial information, management discussion, and corporate governance data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2021-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.